carboxyamidotriazole orotate

carboxyamidotriazole orotate

An angiogenesis inhibitor in clinical trials as an ancillary cancer therapy, which may act by inhibiting the influx of CA2+ into cells and suppressing proliferation of advanced solid tumours and endothelial cells.